U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.3462del (p.Thr1155fs) AND Familial cancer of breast

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 1, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000585690.3

Allele description [Variation Report for NM_000059.4(BRCA2):c.3462del (p.Thr1155fs)]

NM_000059.4(BRCA2):c.3462del (p.Thr1155fs)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.3462del (p.Thr1155fs)
HGVS:
  • NC_000013.11:g.32337817del
  • NG_012772.3:g.27338del
  • NM_000059.4:c.3462delMANE SELECT
  • NP_000050.3:p.Thr1155fs
  • LRG_293:g.27338del
  • NC_000013.10:g.32911953del
  • NC_000013.10:g.32911954del
  • NM_000059.3:c.3462delC
Protein change:
T1155fs
Links:
dbSNP: rs1555283256
NCBI 1000 Genomes Browser:
rs1555283256
Molecular consequence:
  • NM_000059.4:c.3462del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Familial cancer of breast
Synonyms:
Breast cancer, familial; Hereditary breast cancer
Identifiers:
MONDO: MONDO:0016419; MedGen: C0346153; OMIM: 114480

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000693563GeneKor MSA
criteria provided, single submitter

(ACMG Guidelines, 2015)		Pathogenic
(Jan 1, 2020) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From GeneKor MSA, SCV000693563.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change deletes one nucleotide in exon 11 of BRCA2 mRNA (c.3462delC), causing a frameshift at codon 1155 and the creation of a premature translation stop signal 13 amino acid residues later. This is expected to result in an absent or disrupted protein product. Truncating variants in BRCA2 are known to be pathogenic.The mutation database Clinvar contains entries for this variant (Variation ID: 462293).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 8, 2024